1-6 of 6
Lutz Peter Mueller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups

Sonia Jaramillo Segura, Maxi Wass, Judith Schaffrath, Kathrin Rieger, Axel Nogai, Mathias Haenel, Regina Herbst, Friedrich Stoelzel, Christoph Röllig, Edgar Jost, Richard F. Schlenk, Richard Noppeney, Christian H. Brandts, Utz Krug, Katharina S. Goetze, Sebastian Buske, Axel Florschütz, Jörg Schubert, Bernhard Opitz, Martin Mohren, Eva Eßeling, Stephan von Witzendorff, Marion Subklewe, Martin Kaufmann, Norbert Frickhofen, Christian W Scholz, Kerstin Schäfer-Eckart, Volker Kunzmann, Martin Schmidt-Hieber, Herbert G. Sayer, Andreas Rank, Philipp Hemmati, Frank Schueler, Simone Kowoll, Marina Scheller, Jörg Steighardt, Bayram Edemir, Lutz Peter Mueller, Irit Gliko-Kabir, Beatrice Ludwig-Kraus, Sabine Edemir, Ella Sorani, Mascha Binder, Abi Vainstein, Shaul Kadosh, Cora Gromann, Andreas Wienke, Claudia D. Baldus, Uwe Platzbecker, Hubert Serve, Martin Bornhaeuser, Christian Junghanss, Carsten Mueller-Tidow
Journal: Blood
Blood (2022) 140 (Supplement 1): 3338–3340.
https://doi.org/10.1182/blood-2022-166748
Published: 2022
Journal Articles

In Patients with Relapsed/Refractory AML Sequential Conditioning and Immediate Allogeneic Stem Cell Transplantation (allo-HCT) Results in Similar Overall and Leukemia-Free Survival Compared to Intensive Remission Induction Chemotherapy Followed By Allo-HCT: Results from the Randomized Phase III ASAP Trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva-Maria Wagner, Lutz Peter Mueller, Schmid Christoph, Stefan W. Krause, Wolfgang Bethge, Edgar Jost, Uwe Platzbecker, Stefan Klein, Jörg Schubert, Judith Niederland, Martin Kaufmann, Kerstin Schäfer-Eckart, Markus Schaich, Henning Baldauf, Friedrich Stölzel, Cathleen Petzold, Christoph Röllig, Nael Alakel, Björn Steffen, Beate Hauptrock, Christian Reicherts, Christoph Schliemann, Hubert Serve, Alexander H. Schmidt, Martin Bornhäuser, Jan-Henrik Mikesch, Johannes Schetelig
Journal: Blood
Blood (2022) 140 (Supplement 1): 9–11.
https://doi.org/10.1182/blood-2022-159962
Published: 2022
Journal Articles

Genetic and Epigenetic Changes at Secondary Resistance after Continued Treatment in the Randomized Phase II Study of All- Trans Retinoic Acid (ATRA) and/or Valproic Acid (VPA) Added to Decitabine (DAC) in Newly Diagnosed Elderly AML Patients (DECIDER Trial)

Inga Hund, Maria Hess, Julia Stomper, Gabriele Greve, Jan Mitschke, Christoph Niemöller, Tobias Ma, David Uhl, Felicitas R. Thol, Michael Heuser, Gesine Bug, Martina Crysandt, Lutz Peter Mueller, Andreas Neubauer, Justus Duyster, Hartmut Dohner, Melanie Boerries, Heiko Becker, Michael Luebbert
Journal: Blood
Blood (2022) 140 (Supplement 1): 3383–3384.
https://doi.org/10.1182/blood-2022-163220
Published: 2022
Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Patients ≤ 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial-

Martin Bornhaeuser, Christoph Schliemann, Johannes Schetelig, Christoph Rollig, Michael Kramer, Bertram Glass, Uwe Platzbecker, Andreas Burchert, Mathias Haenel, Lutz Peter Mueller, Stefan Klein, Gesine Bug, Dietrich W. Beelen, Wolf Roesler, Kerstin Schaefer-Eckart, Christoph Schmid, Edgar Jost, Georg Lenz, Johanna Tischer, Karsten Spiekermann, Markus Pfirrmann, Hubert Serve, Friedrich Stoelzel, Nael Alakel, Gerhard Ehninger, Wolfgang E. Berdel, Matthias Stelljes
Journal: Blood
Blood (2021) 138 (Supplement 1): 173.
https://doi.org/10.1182/blood-2021-145167
Published: 2021
Journal Articles

Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation with Venetoclax, Hypomethylating Agents and DLI - a Retrospective Multi Center Study

Esther Schuler, MD, Eva-Maria Wagner-Drouet, MD, Salem Ajib, MD, Gesine Bug, Martina Crysandt, MD, Sabine Dressler, MD, Andreas Hausmann, MD, Daniela Heidenreich, MD, Klaus Hirschbühl, MD, Matthias Hoepting, MD, Edgar Jost, MD, Jennifer Kaivers, MD, Stefan A Klein, MD, Lambros Kordelas, MD, Oliver Kriege, MD, Lutz Peter Mueller, MD, Christina Rautenberg, MD, Judith Schaffrath, MD, Christoph Schmid, MD, Daniel Wolff, MD, Martin Bornhaeuser, MD, Thomas Schroeder, MD, Guido Kobbe, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4563.
https://doi.org/10.1182/blood-2019-125087
Published: 2019
Journal Articles

Marked Improvement of Skin Involvement in Severe Progressive Systemic Sclerosis after Transplantation of Mesenchymal Stem Cells from an Allogeneic Haploidentical Related Donor.

Maximilian Christopeit, MD, Marit Schendel, MD, Lutz Peter Mueller, MD, Gernot Keyszer, MD, Gerhard Behre, MD
Journal: Blood
Blood (2007) 110 (11): 4865.
https://doi.org/10.1182/blood.V110.11.4865.4865
Published: 2007